Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Francesco Cognetti
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Procedures
Disorders
Chemicals & Drugs
Concepts & Ideas
Sign-in to see full Profile
Network (preview)
58
Fabi, Alessandra
56
Carlini, Paolo
50
Papaldo, Paola
49
Giannarelli, Diana
39
Ferretti, Gianluigi
39
Bria, Emilio
38
Milella, Michele
34
Terzoli, Edmondo
25
gelibter, alain
24
Ruggeri, Enzo Maria
23
Cuppone, Federica
22
Felici, Alessandra
21
Ciccarese, Mariangela
21
Nisticò, Cecilia
21
Sperduti, Isabella
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Francesco Cognetti (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Bria Emilio; Milella Michele; Sperduti Isabella; Alessandrini Gabriele; Visca Paolo; Corzani Felicita; Giannarelli Diana; Cerasoli Virna; Cuppone Federica; Cecere Fabiana Letizia; Marchetti Antonio; Sacco Rocco; Mucilli Felice; Malatesta Sara; Guetti Luigi; Vitale Luca; Ceribelli Anna; Rinaldi Massimo; Terzoli Edmondo; Cognetti Francesco; Facciolo Francesco
A novel clinical prognostic score incorporating the number of resected lymph-nodes to predict recurrence and survival in non-small-cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2009;66(3):365-71.
-
2009: Petronelli Alessia; Saulle Ernestina; Pasquini Luca; Petrucci Eleonora; Mariani Gualtiero; Biffoni Mauro; Ferretti Gianluigi; Scambia Giovanni; Benedetti-Panici Pierluigi; Greggi Stefano; Cognetti Francesco; Russo Matteo Antonio; Sporn Michael; Testa Ugo
High sensitivity of ovarian cancer cells to the synthetic triterpenoid CDDO-Imidazolide.
Cancer letters 2009;282(2):214-28.
-
2009: Ciuffreda Ludovica; Del Bufalo Donatella; Desideri Marianna; Di Sanza Cristina; Stoppacciaro Antonella; Ricciardi Maria Rosaria; Chiaretti Sabina; Tavolaro Simona; Benassi Barbara; Bellacosa Alfonso; Foà Robin; Tafuri Agostino; Cognetti Francesco; Anichini Andrea; Zupi Gabriella; Milella Michele
Growth-inhibitory and antiangiogenic activity of the MEK inhibitor PD0325901 in malignant melanoma with or without BRAF mutations.
Neoplasia (New York, N.Y.) 2009;11(8):720-31.
-
2009: Bria Emilio; Cuppone Federica; Giannarelli Diana; Milella Michele; Ruggeri Enzo Maria; Sperduti Isabella; Pinnarò Paola; Terzoli Edmondo; Cognetti Francesco; Carlini Paolo
Does hormone treatment added to radiotherapy improve outcome in locally advanced prostate cancer?: meta-analysis of randomized trials.
Cancer 2009;115(15):3446-56.
-
2009: Fabi Alessandra; Russillo Michelangelo; Metro Giulio; Vidiri Antonello; Di Giovanni Salvatore; Cognetti Francesco
Pseudoprogression and MGMT status in glioblastoma patients: implications in clinical practice.
Anticancer research 2009;29(7):2607-10.
-
2009: Nisticò Cecilia; Bria Emilio; Vaccaro Vanja; Cuppone Federica; Fornier Monica; Sperduti Isabella; Carpino Armando; Izzo Fiorentino; Tropea Francesco; Cognetti Francesco; Terzoli Edmondo
Trastuzumab plus weekly epirubicin and paclitaxel for locally advanced and metastatic breast cancer: preliminary results of a feasibility-phase II study aimed at cardiotoxicity.
Anti-cancer drugs 2009;20(2):109-14.
-
2009: Nisticò Paola; Capone Imerio; Palermo Belinda; Del Bello Duilia; Ferraresi Virginia; Moschella Federica; Aricò Eleonora; Valentini Mara; Bracci Laura; Cognetti Francesco; Ciccarese Mariangela; Vercillo Giuseppe; Roselli Mario; Fossile Emanuela; Tosti Maria Elena; Wang Ena; Marincola Francesco; Imberti Luisa; Catricalà Caterina; Natali Pier Giorgio; Belardelli Filippo; Proietti Enrico
Chemotherapy enhances vaccine-induced antitumor immunity in melanoma patients.
International journal of cancer. Journal international du cancer 2009;124(1):130-9.
-
2009: Fabi Alessandra; Metro Giulio; Russillo Michelangelo; Vidiri Antonello; Carapella Carmine Maria; Maschio Marta; Cognetti Francesco; Jandolo Bruno; Mirri Maria Alessandra; Sperduti Isabella; Telera Stefano; Carosi Mariantonia; Pace Andrea
Treatment of recurrent malignant gliomas with fotemustine monotherapy: impact of dose and correlation with MGMT promoter methylation.
BMC cancer 2009;9():101.
-
2009: Pino Maria S; Milella Michele; Gelibter Alain; Sperduti Isabella; De Marco Salvatore; Nuzzo Carmen; Bria Emilio; Carpanese Livio; Ruggeri Enzo M; Carlini Paolo; Cognetti Francesco
Capecitabine and celecoxib as second-line treatment of advanced pancreatic and biliary tract cancers.
Oncology 2009;76(4):254-61.
-
2008: Bria Emilio; Cuppone Federica; Milella Michele; Verma Sunil; Carlini Paolo; Nisticò Cecilia; Vaccaro Vanja; Rossi Antonio; Tonini Giuseppe; Cognetti Francesco; Terzoli Edmondo
Trastuzumab cardiotoxicity: biological hypotheses and clinical open issues.
Expert opinion on biological therapy 2008;8(12):1963-71.
-
2008: Fabi Alessandra; Ciccarese Mariangela; Metro Giulio; Savarese Antonella; Giannarelli Diana; Nuzzo Carmen M; Russillo Michelangelo; Sperduti Isabella; Carbone Ilaria; Bria Emilio; Cognetti Francesco
Oral ondansetron is highly active as rescue antiemetic treatment for moderately emetogenic chemotherapy: results of a randomized phase II study.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2008;16(12):1375-80.
-
2008: Ferraresi Virginia; Ciccarese Mariangela; Cercato Maria Cecilia; Nuzzo Carmen; Zeuli Massimo; Di Filippo Franco; Giannarelli Diana; Cognetti Francesco
Gemcitabine at fixed dose-rate in patients with advanced soft-tissue sarcomas: a mono-institutional phase II study.
Cancer chemotherapy and pharmacology 2008;63(1):149-55.
-
2008: Guarneri Valentina; Frassoldati Antonio; Bruzzi Paolo; D'Amico Roberto; Belfiglio Maurizio; Molino Annamaria; Bertetto Oscar; Cascinu Stefano; Cognetti Francesco; Di Leo Angelo; Pronzato Paolo; Crinó Lucio; Agostara Biagio; Conte PierFranco
Multicentric, randomized phase III trial of two different adjuvant chemotherapy regimens plus three versus twelve months of trastuzumab in patients with HER2- positive breast cancer (Short-HER Trial; NCT00629278).
Clinical breast cancer 2008;8(5):453-6.
-
2008: Fabi Alessandra; Metro Giulio; Ferretti Gianluigi; Giannarelli Diana; Di Cosimo Serena; Papaldo Paola; Mottolese Marcella; Carlini Paolo; Felici Alessandra; Russillo Michelangelo; Cognetti Francesco
Do HER-2 positive metastatic breast cancer patients benefit from the use of trastuzumab beyond disease progression? A mono-institutional experience and systematic review of observational studies.
Breast (Edinburgh, Scotland) 2008;17(5):499-505.
-
2008: Fabi Alessandra; Metro Giulio; Papaldo Paola; Mottolese Marcella; Melucci Elisa; Carlini Paolo; Sperduti Isabella; Russillo Michelangelo; Gelibter Alain; Ferretti Gianluigi; Tomao Silverio; Milella Michele; Cognetti Francesco
Impact of celecoxib on capecitabine tolerability and activity in pretreated metastatic breast cancer: results of a phase II study with biomarker evaluation.
Cancer chemotherapy and pharmacology 2008;62(4):717-25.
-
2008: Cuppone Federica; Bria Emilio; Carlini Paolo; Milella Michele; Felici Alessandra; Sperduti Isabella; Nisticò Cecilia; Terzoli Edmondo; Cognetti Francesco; Giannarelli Diana
Taxanes as primary chemotherapy for early breast cancer: meta-analysis of randomized trials.
Cancer 2008;113(2):238-46.
-
2008: Pino Maria Simona; Gamucci Teresa; Mansueto Giovanni; Trapasso Tiziana; Narducci Filomena; Giampaolo Maria Anna; Fariello Anna Maria; Sperduti Isabella; Ceribelli Anna; Cognetti Francesco
A phase II study of biweekly paclitaxel (P) and gemcitabine (G), followed by maintenance weekly paclitaxel in elderly patients with advanced non-small cell lung cancer (NSCLC).
Lung cancer (Amsterdam, Netherlands) 2008;60(3):381-6.
-
2008: Bria Emilio; Cuppone Federica; Fornier Monica; Nisticò Cecilia; Carlini Paolo; Milella Michele; Sperduti Isabella; Terzoli Edmondo; Cognetti Francesco; Giannarelli Diana
Cardiotoxicity and incidence of brain metastases after adjuvant trastuzumab for early breast cancer: the dark side of the moon? A meta-analysis of the randomized trials.
Breast cancer research and treatment 2008;109(2):231-9.
-
2008: Nuzzo Carmen; Zeuli Massimo; Ferraresi Virginia; Ciccarese Mariangela; Pelligrini Domenica; Cognetti Francesco
Unexpected clinical outcome in a patient with liver and brain metastasis from melanoma.
Anticancer research 2008;28(2B):1429-31.
-
2008: Metro Giulio; Fabi Alessandra; Russillo Michelangelo; Papaldo Paola; De Laurentiis Michelino; Ferretti Gianluigi; Pellegrini Domenica; Nuzzo Carmen; Graziano Vanessa; Vici Patrizia; Introna Marianna; Felici Alessandra; Cognetti Francesco; Carlini Paolo
Taxanes and gemcitabine doublets in the management of HER-2 negative metastatic breast cancer: towards optimization of association and schedule.
Anticancer research 2008;28(2B):1245-58.
-
2008: Fabi Alessandra; Mirri Alessandra; Felici Alessandra; Vidiri Antonello; Pace Andrea; Occhipinti Emanuele; Cognetti Francesco; Arcangeli Giorgio; Iandolo Bruno; Carosi Maria Antonia; Metro Giulio; Carapella Carmine Maria
Fixed dose-rate gemcitabine as radiosensitizer for newly diagnosed glioblastoma: a dose-finding study.
Journal of neuro-oncology 2008;87(1):79-84.
-
2008: Gelibter Alain J; Di Segni Susanna; Zeuli Massimo; Cognetti Francesco
Bevacizumab: one treatment for all the seasons?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(3):511; author reply 511-2.
-
2008: Ferretti Gianluigi; Felici Alessandra; Cognetti Francesco
HER2 and response to paclitaxel in node-positive breast cancer.
The New England journal of medicine 2008;358(2):197; author reply 198.
-
2008: Cuppone Federica; Bria Emilio; Verma Sunil; Pritchard Kathleen I; Gandhi Sonal; Carlini Paolo; Milella Michele; Nisticò Cecilia; Terzoli Edmondo; Cognetti Francesco; Giannarelli Diana
Do adjuvant aromatase inhibitors increase the cardiovascular risk in postmenopausal women with early breast cancer? Meta-analysis of randomized trials.
Cancer 2008;112(2):260-7.
-
2007: Salesi N; Russillo M; Marandino F; Ruggeri E M; Metro G; Cognetti F; Fabi A
Bone of the hands as unusual metastastatic site of renal cell carcinoma.
Journal of experimental & clinical cancer research : CR 2007;26(4):595-7.
-
2007: Metro Giulio; Sperduti Isabella; Russillo Michelangelo; Milella Michele; Cognetti Francesco; Fabi Alessandra
Clinical utility of continuing trastuzumab beyond brain progression in HER-2 positive metastatic breast cancer.
The oncologist 2007;12(12):1467-9; author reply 1469-71.
-
2007: Ferretti Gianluigi; Fabi Alessandra; Carlini Paolo; Papaldo Paola; Felici Alessandra; Tomao Silverio; Cognetti Francesco
Zoledronic acid and angiogenesis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(22 Pt 1):6850; author reply 6850-1.
-
2007: Ferretti Gianluigi; Felici Alessandra; Cognetti Francesco
Re: Treatment of human epidermal growth factor receptor 2 overexpressing breast cancer xenografts with multiagent human epidermal growth factor receptor targeted therapy.
Journal of the National Cancer Institute 2007;99(21):1644; author reply 1644-6.
-
2007: Ferretti Gianluigi; Felici Alessandra; Cognetti Francesco; Mandala Mario
Transforming growth factor-beta signaling and regulatory T cells.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(29):4695-6; author reply 4696-7.
-
2007: Ferretti Gianluigi; Felici Alessandra; Carlini Paolo; Cognetti Francesco
Re: Polychemotherapy for early breast cancer: results from the international adjuvant breast cancer chemotherapy randomized Trial.
Journal of the National Cancer Institute 2007;99(18):1416.
-
2007: Ferretti Gianluigi; Felici Alessandra; Carlini Paolo; Cognetti Francesco
Re: Ovarian ablation or suppression in premenopausal early breast cancer: results from the International Adjuvant Breast Cancer Ovarian Ablation or Suppression randomized trial.
Journal of the National Cancer Institute 2007;99(17):1344-5.
-
2007: Gelibter Alain J; Gamucci Teresa; Pollera Camillo F; Di Costanzo Francesco; Nuzzo Carmen; Gabriele Angela; Signorelli Carlo; Gasperoni Silvia; Ferraresi Virginia; Giannarelli Diana; Cognetti Francesco; Zeuli Massimo
A phase II trial of gefitinib in combination with capecitabine and oxaliplatin as first-line chemotherapy in patients with advanced colorectal cancer.
Current medical research and opinion 2007;23(9):2117-23.
-
2007: Roché Henri; Yelle Louise; Cognetti Francesco; Mauriac Louis; Bunnell Craig; Sparano Joseph; Kerbrat Pierre; Delord Jean-Pierre; Vahdat Linda; Peck Ronald; Lebwohl David; Ezzeddine Rana; Curé Hervé
Phase II clinical trial of ixabepilone (BMS-247550), an epothilone B analog, as first-line therapy in patients with metastatic breast cancer previously treated with anthracycline chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(23):3415-20.
-
2007: Bria Emilio; Milella Michele; Gelibter Alain; Cuppone Federica; Pino Maria Simona; Ruggeri Enzo Maria; Carlini Paolo; Nisticò Cecilia; Terzoli Edmondo; Cognetti Francesco; Giannarelli Diana
Gemcitabine-based combinations for inoperable pancreatic cancer: have we made real progress? A meta-analysis of 20 phase 3 trials.
Cancer 2007;110(3):525-33.
-
2007: Nisticò Cecilia; Bria Emilio; Cuppone Federica; Fornier Monica; Sperduti Isabella; Carpino Armando; Pace Andrea; Cognetti Francesco; Terzoli Edmondo
Weekly epirubicin and paclitaxel with granulocyte colony-stimulating factor support in previously untreated metastatic breast cancer patients: a phase II study.
Anti-cancer drugs 2007;18(6):687-92.
-
2007: Carlini Paolo; Bria Emilio; Giannarelli Diana; Felici Alessandra; Papaldo Paola; Fabi Alessandra; Ruggeri Enzo Maria; Milella Michele; Nuzzo Carmen; Cecere Fabiana Letizia; Gelibter Alain; Pino Maria Simona; Nisticò Cecilia; Cuppone Federica; Metro Giulio; Terzoli Edmondo; Cognetti Francesco; Ferretti Gianluigi
Aromatase inhibitors in post-menopausal metastatic breast carcinoma.
Expert opinion on investigational drugs 2007;16(7):1023-36.
-
2007: Ferretti Gianluigi; Fabi Alessandra; Carlini Paolo; Papaldo Paola; Felici Alessandra; Cognetti Francesco
Antitumor effects of clinical dosing regimens of bisphosphonates in experimental breast cancer bone metastasis.
Bone 2007;41(1):155-6.
-
2007: Gridelli Cesare; Gallo Ciro; Ceribelli Anna; Gebbia Vittorio; Gamucci Teresa; Ciardiello Fortunato; Carozza Francesco; Favaretto Adolfo; Daniele Bruno; Galetta Domenico; Barbera Santi; Rosetti Francesco; Rossi Antonio; Maione Paolo; Cognetti Francesco; Testa Antonio; Di Maio Massimo; Morabito Alessandro; Perrone Francesco;
Factorial phase III randomised trial of rofecoxib and prolonged constant infusion of gemcitabine in advanced non-small-cell lung cancer: the GEmcitabine-COxib in NSCLC (GECO) study.
The lancet oncology 2007;8(6):500-12.
-
2007: Tortora Giampaolo; Bianco Roberto; Daniele Gennaro; Ciardiello Fortunato; McCubrey James A; Ricciardi Maria Rosaria; Ciuffreda Ludovica; Cognetti Francesco; Tafuri Agostino; Milella Michele
Overcoming resistance to molecularly targeted anticancer therapies: Rational drug combinations based on EGFR and MAPK inhibition for solid tumours and haematologic malignancies.
Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 2007;10(3):81-100.
-
2007: Ferretti Gianluigi; Felici Alessandra; Carlini Paolo; Cognetti Francesco
Exemestane or tamoxifen?
Lancet 2007;369(9573):1599; author reply 1600-1.
-
2007: Bria Emilio; Cuppone Federica; Cecere Fabiana Letizia; Milella Michele; Nisticò Cecilia; Cognetti Francesco; Terzoli Edmondo
Adjuvant chemotherapy for non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2007;2(5 Suppl):S7-11.
-
2007: Petrucci Eleonora; Pasquini Luca; Petronelli Alessia; Saulle Ernestina; Mariani Gualtiero; Riccioni Roberta; Biffoni Mauro; Ferretti Gianluigi; Benedetti-Panici Pieluigi; Cognetti Francesco; Scambia Giovanni; Humphreys Robin; Peschle Cesare; Testa Ugo
A small molecule Smac mimic potentiates TRAIL-mediated cell death of ovarian cancer cells.
Gynecologic oncology 2007;105(2):481-92.
-
2007: Ferretti Gianluigi; Felici Alessandra; Cognetti Francesco
Re: Age-related lobular involution and risk of breast cancer.
Journal of the National Cancer Institute 2007;99(7):571-2; author reply 572.
-
2007: Saulle Ernestina; Petronelli Alessia; Pasquini Luca; Petrucci Eleonora; Mariani Gualtiero; Biffoni Mauro; Ferretti Gianluigi; Scambia Giovanni; Benedetti-Panici Pierluigi; Cognetti Francesco; Humphreys Robin; Peschle Cesare; Testa Ugo
Proteasome inhibitors sensitize ovarian cancer cells to TRAIL induced apoptosis.
Apoptosis : an international journal on programmed cell death 2007;12(4):635-55.
-
2007: Carlini Paolo; Michelotti Andrea; Ferretti Gianluigi; Ricci Sergio; Giannarelli Diana; Pellegrini Manuela; Cresti Nicola; Di Cosimo Serena; Bria Emilio; Papaldo Paola; Fabi Alessandra; Ruggeri Enzo Maria; Milella Michele; Alimonti Andrea; Salesi Nello; Cognetti Francesco
Clinical evaluation of the use of exemestane as further hormonal therapy after nonsteroidal aromatase inhibitors in postmenopausal metastatic breast cancer patients.
Cancer investigation 2007;25(2):102-5.
-
2007: Ferretti Gianluigi; Felici Alessandra; Cognetti Francesco
Pregnancy levels of estrogen and progesterone: the double-edged sword.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007;16(3):634; author reply 634-5.
-
2007: Milella Michele; Konopleva Marina; Precupanu Cristina M; Tabe Yoko; Ricciardi Maria Rosaria; Gregorj Chiara; Collins Steven J; Carter Bing Z; D'Angelo Carmen; Petrucci Maria Teresa; Foà Robin; Cognetti Francesco; Tafuri Agostino; Andreeff Michael
MEK blockade converts AML differentiating response to retinoids into extensive apoptosis.
Blood 2007;109(5):2121-9.
-
2007: Gasparini Giampietro; Gion Massimo; Mariani Luigi; Papaldo Paola; Crivellari Diana; Filippelli Gianfranco; Morabito Alessandro; Silingardi Vittorio; Torino Francesco; Spada Antonella; Zancan Matelda; De Sio Livia; Caputo Antonio; Cognetti Francesco; Lambiase Antonio; Amadori Dino
Randomized Phase II Trial of weekly paclitaxel alone versus trastuzumab plus weekly paclitaxel as first-line therapy of patients with Her-2 positive advanced breast cancer.
Breast cancer research and treatment 2007;101(3):355-65.
-
2007: Gelibter Alain J; Di Segni Susanna; Zeuli Massimo; Milella Michele; Ferretti Gianluigi; Nuzzo Carmen; Cognetti Francesco
Old age: biologic versus chronologic.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(6):e8.
-
2007: Bria Emilio; Di Maio Massimo; Cuppone Federica; Nisticò Cecilia; Cognetti Francesco; Giannarelli Diana
Should subgroup analysis of randomized clinical trials have a direct impact on clinical practice?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(5):605-6; author reply 606-7.
-
2007: Mottolese Marcella; Orlandi Giulia; Sperduti Isabella; Merola Roberta; Buglioni Simonetta; Di Benedetto Anna; Pinnarò Paola; Perracchio Letizia; Venturo Irene; Cognetti Francesco; Cianciulli AnnaMaria
Bio-pathologic characteristics related to chromosome 11 aneusomy and cyclin D1 gene status in surgically resected stage I and II breast cancer: Identification of an adverse prognostic profile.
The American journal of surgical pathology 2007;31(2):247-54.
-
2007: Ceribelli Anna; Pino Maria S; Gelibter Alain J; Milella Michele; Cecere Fabiana L; Caterino Mauro; Facciolo Francesco; Mirri Alessandra; Cognetti Francesco
Sequential chemotherapy in nonsmall-cell lung cancer: cisplatin and gemcitabine followed by docetaxel.
Cancer 2007;109(4):727-31.
-
2007: Ferretti Gianluigi; Felici Alessandra; Papaldo Paola; Fabi Alessandra; Cognetti Francesco
HER2/neu role in breast cancer: from a prognostic foe to a predictive friend.
Current opinion in obstetrics & gynecology 2007;19(1):56-62.
-
2007: Nisticò Cecilia; Bria Emilio; Cuppone Federica; Carpino Armando; Ferretti Gianluigi; Vitelli Gaetano; Sperduti Isabella; Calabretta Francesca; Toglia Giuseppe; Tomao Silverio; Cognetti Francesco; Terzoli Edmondo
Troponin-T and myoglobin plus echocardiographic evaluation for monitoring early cardiotoxicity of weekly epirubicin-paclitaxel in metastatic breast cancer patients.
Anti-cancer drugs 2007;18(2):227-32.
-
2007: Bria Emilio; Ruggeri Enzo Maria; Pollera Camillo Francesco; Terzoli Edmondo; Cognetti Francesco; Giannarelli Diana
Adjuvant chemotherapy for bladder cancer: the chance for meta-analyses comparison.
European urology 2007;51(2):576-7.
-
2007: Bria Emilio; Carlini Paolo; Cognetti Francesco; Terzoli Edmondo; Giannarelli Diana
Re: Survival with aromatase inhibitors and inactivators versus standard hormonal therapy in advanced breast cancer: meta-analysis.
Journal of the National Cancer Institute 2007;99(2):176; author reply 176-7.
-
2007: Ferretti Gianluigi; Felici Alessandra; Cognetti Francesco
The protective side of progesterone.
Breast cancer research : BCR 2007;9(6):402.
-
2007: Ferretti Gianluigi; Giannarelli Diana; Carlini Paolo; Felici Alessandra; Ciccarese Mariangela; Mandalà Mario; Cognetti Francesco
Self-monitoring versus standard monitoring of oral anticoagulation.
Thrombosis research 2007;119(3):389-90.
-
2007: Ferretti Gianluigi; Bria Emilio; Giannarelli Diana; Carlini Paolo; Felici Alessandra; Mandalà Mario; Ciccarese Mariangela; Papaldo Paola; Fabi Alessandra; Cognetti Francesco
Major bleedings in the comparisons between low-molecular weight heparin versus oral anticoagulant therapy for venous thromboembolism.
Thrombosis research 2007;119(4):525-9.
-
2006: Ferretti Gianluigi; Bria Emilio; Giannarelli Diana; Carlini Paolo; Felici Alessandra; Mandalà Mario; Papaldo Paola; Fabi Alessandra; Ciccarese Mariangela; Cuppone Federica; Cecere Fabiana Letizia; Nuzzo Carmen; Terzoli Edmondo; Cognetti Francesco
Is recurrent venous thromboembolism after therapy reduced by low-molecular-weight heparin compared with oral anticoagulants?
Chest 2006;130(6):1808-16.
-
2006: Ferretti Gianluigi; Lopez Massimo; Terzoli Edmondo; Cortesi Enrico; Antimi Mauro; Marolla Paolo; Giannarelli Diana; Cognetti Francesco; Papaldo Paola
Myeloid toxicity in breast cancer patients receiving adjuvant chemotherapy: what is the appropriate use of filgrastim?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(35):5618-9.
-
2006: Carlini Paolo; Papaldo Paola; Fabi Alessandra; Felici Alessandra; Ruggeri Enzo Maria; Milella Michele; Ciccarese Mariangela; Nuzzo Carmen; Cognetti Francesco; Ferretti Gianluigi
Liver toxicity after treatment with gefitinib and anastrozole: drug-drug interactions through cytochrome p450?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(35):e60-1.
-
2006: Ferretti Gianluigi; Felici Alessandra; Pino Maria Simona; Cognetti Francesco
Does CTLA4 influence the suppressive effect of CD25+CD4+ regulatory T cells?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(34):5469-70; author reply 5470-1.
-
2006: Bria Emilio; Cuppone Federica; Ciccarese Mariangela; Nisticò Cecilia; Facciolo Francesco; Milella Michele; Izzo Fiorentino; Terzoli Edmondo; Cognetti Francesco; Giannarelli Diana
Weekly docetaxel as second line chemotherapy for advanced non-small-cell lung cancer: meta-analysis of randomized trials.
Cancer treatment reviews 2006;32(8):583-7.
-
2006: Ferraresi Virginia; Catricalà Caterina; Ciccarese Mariangela; Ferrari Angela; Zeuli Massimo; Cognetti Francesco
Severe skin reaction in a patient with gastrointestinal stromal tumor treated with imatinib mesylate.
Anticancer research 2006;26(6C):4771-4.
-
2006: Nisticò Cecilia; Cuppone Federica; Bria Emilio; Fornier Monica; Giannarelli Diana; Mottolese Marcella; Novelli Flavia; Natoli Guido; Cognetti Francesco; Terzoli Edmondo
Ten years of experience with weekly chemotherapy in metastatic breast cancer patients: multivariate analysis of prognostic factors.
Anti-cancer drugs 2006;17(10):1193-200.
-
2006: Spugnini Enrico P; Cardillo Irene; Verdina Alessandra; Crispi Stefania; Saviozzi Silvia; Calogero Raffaele; Nebbioso Angela; Altucci Lucia; Cortese Giancarlo; Galati Rossella; Chien Jeremy; Shridhar Viji; Vincenzi Bruno; Citro Gennaro; Cognetti Francesco; Sacchi Ada; Baldi Alfonso
Piroxicam and cisplatin in a mouse model of peritoneal mesothelioma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(20 Pt 1):6133-43.
-
2006: Gelibter Alain J; Lonardi Sara; Di Segni Susanna; Fontana Andrea; Loupakis Fotios; Cognetti Francesco; Labianca Roberto
Are dose-finding studies still necessary when targeted therapy is associated with chemotherapy?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(28):4668-9; author reply 4669.
-
2006: Bria E; Di Maio M; Nisticò C; Cuppone F; Terzoli E; Cognetti F; Giannarelli D
Factorial design for randomized clinical trials.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(10):1607-8.
-
2006: Ferretti G; Bria E; Giannarelli D; Carlini P; Felici A; Mandalà M; Papaldo P; Fabi A; Ciccarese M; Cognetti F
Does low-molecular-weight heparin influence cancer-related mortality?
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(10):1604-6.
-
2006: Fabi Alessandra; Nuzzo Carmen; Vidiri Antonello; Ciccarese Mariangela; Felici Alessandra; Cattani Fabio; Cognetti Francesco
Bone and lung metastases from intracranial meningioma.
Anticancer research 2006;26(5B):3835-7.
-
2006: Ferretti Gianluigi; Papaldo Paola; Cognetti Francesco
Lineage-specific hematopoietic growth factors.
The New England journal of medicine 2006;355(5):526; author reply 527.
-
2006: Bria Emilio; Ciccarese Mariangela; Giannarelli Diana; Cuppone Federica; Nisticò Cecilia; Nuzzo Carmen; Natoli Guido; Fabi Alessandra; Terzoli Edmondo; Cognetti Francesco; Carlini Paolo
Early switch with aromatase inhibitors as adjuvant hormonal therapy for postmenopausal breast cancer: pooled-analysis of 8794 patients.
Cancer treatment reviews 2006;32(5):325-32.
-
2006: Ferretti Gianluigi; Papaldo Paola; Fabi Alessandra; Carlini Paolo; Felici Alessandra; Cognetti Francesco
Adjuvant trastuzumab with docetaxel or vinorelbine for HER-2-positive breast cancer.
The oncologist 2006;11(7):853-4.
-
2006: Papaldo Paola; Ferretti Gianluigi; Di Cosimo Serena; Giannarelli Diana; Marolla Paolo; Lopez Massimo; Cortesi Enrico; Antimi Mauro; Terzoli Edmondo; Carlini Paolo; Vici Patrizia; Botti Claudio; Di Lauro Luigi; Naso Giuseppe; Nisticò Cecilia; Mottolese Marcella; Di Filippo Franco; Ruggeri Enzo Maria; Ceribelli Anna; Cognetti Francesco
Does granulocyte colony-stimulating factor worsen anemia in early breast cancer patients treated with epirubicin and cyclophosphamide?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(19):3048-55.
-
2006: Merola R; Mottolese M; Orlandi G; Vico E; Cognetti F; Sperduti I; Fabi A; Vitelli G; Cianciulli A M
Analysis of aneusomy level and HER-2 gene copy number and their effect on amplification rate in breast cancer specimens read as 2+ in immunohistochemical analysis.
European journal of cancer (Oxford, England : 1990) 2006;42(10):1501-6.
-
2006: Fabi A; Vidiri A; Ferretti G; Felici A; Papaldo P; Carlini P; Mirri A; Nuzzo C; Cognetti F
Dramatic regression of multiple brain metastases from breast cancer with Capecitabine: another arrow at the bow?
Cancer investigation 2006;24(4):466-8.
-
2006: Ferretti Gianluigi; Fabi Alessandra; Carlini Paolo; Papaldo Paola; Felici Alessandra; Cognetti Francesco
What is the biological significance of circulating blood levels of metalloproteinases?
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(11 Pt 1):3550-1; author reply 3551.
-
2006: Del Bufalo Donatella; Ciuffreda Ludovica; Trisciuoglio Daniela; Desideri Marianna; Cognetti Francesco; Zupi Gabriella; Milella Michele
Antiangiogenic potential of the Mammalian target of rapamycin inhibitor temsirolimus.
Cancer research 2006;66(11):5549-54.
-
2006: Ferretti G; Bria E; Giannarelli D; Felici A; Papaldo P; Fabi A; Di Cosimo S; Ruggeri E M; Milella M; Ciccarese M; Cecere F L; Gelibter A; Nuzzo C; Cognetti F; Terzoli E; Carlini P
Second- and third-generation aromatase inhibitors as first-line endocrine therapy in postmenopausal metastatic breast cancer patients: a pooled analysis of the randomised trials.
British journal of cancer 2006;94(12):1789-96.
-
2006: Bria Emilio; Nistico Cecilia; Cuppone Federica; Carlini Paolo; Ciccarese Mariangela; Milella Michele; Natoli Guido; Terzoli Edmondo; Cognetti Francesco; Giannarelli Diana
Benefit of taxanes as adjuvant chemotherapy for early breast cancer: pooled analysis of 15,500 patients.
Cancer 2006;106(11):2337-44.
-
2006: Ferretti G; Felici A; Ciccarese M; Papaldo P; Carlini P; Fabi A; Gelibter A; Cognetti F
Molecular stool testing for the early detection of colorectal cancer: swan song for p53?
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(6):1026.
-
2006: Ferretti Gianluigi; Felici Alessandra; Papaldo Paola; Carlini Paolo; Fabi Alessandra; Cognetti Francesco
Trastuzumab combined with paclitaxel after doxorubicin and cyclophosphamide for operable HER2-positive breast cancer.
The oncologist 2006;11(5):533; author reply 534.
-
2006: Ferretti Gianluigi; Felici Alessandra; Cognetti Francesco; Mandala Mario
Is there a right-sided shift for colorectal cancer in women compared with men?
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2006;15(5):1054.
-
2006: Fabi Alessandra; Ferretti Gianluigi; Papaldo Paola; Salesi Nello; Ciccarese Mariangela; Lorusso Vito; Carlini Paolo; Carpino Armando; Mottolese Marcella; Cianciulli Anna Maria; Giannarelli Diana; Sperduti Isabella; Felici Alessandra; Cognetti Francesco
Pegylated liposomal doxorubicin in combination with gemcitabine: a phase II study in anthracycline-naïve and anthracycline pretreated metastatic breast cancer patients.
Cancer chemotherapy and pharmacology 2006;57(5):615-23.
-
2006: Pino Maria S; Shrader Marissa; Baker Cheryl H; Cognetti Francesco; Xiong Henry Q; Abbruzzese James L; McConkey David J
Transforming growth factor alpha expression drives constitutive epidermal growth factor receptor pathway activation and sensitivity to gefitinib (Iressa) in human pancreatic cancer cell lines.
Cancer research 2006;66(7):3802-12.
-
2006: Ceribelli Anna; Cecere Fabiana Letizia; Milella Michele; Facciolo Francesco; Gelibter Alain; Cognetti Francesco
Severe rhabdomyolysis associated with pemetrexed-based chemotherapy.
The lancet oncology 2006;7(4):353.
-
2006: Papaldo P; Fabi A; Ferretti G; Mottolese M; Cianciulli A M; Di Cocco B; Pino M S; Carlini P; Di Cosimo S; Sacchi I; Sperduti I; Nardoni C; Cognetti F
A phase II study on metastatic breast cancer patients treated with weekly vinorelbine with or without trastuzumab according to HER2 expression: changing the natural history of HER2-positive disease.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(4):630-6.
-
2006: Papaldo Paola; Di Cosimo Serena; Ferretti Gianluigi; Carlini Paolo; Fabi Alessandra; Cecere Fabiana; Cognetti Francesco
Is anthracycline-based chemotherapy alone adequate for young women with estrogen receptor-positive breast cancer?
Breast (Edinburgh, Scotland) 2006;15(2):269-72.
-
2006: Bria E; Ceribelli A; Trovò M G; Gelibter A; Gigante M; Calabrò E; Cuppone F; Cognetti F; Terzoli E; Pastorino U
Non-small cell lung cancer: early stages.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17 Suppl 2():ii17-21.
-
2006: Ferretti G; Bria E; Felici A; Carlini P; Giannarelli D; Ciccarese M; Papaldo P; Fabi A; Gelibter A; Cognetti F
Catheter-associated thrombosis: thromboprophylaxis for cancer patients who carry factor V Leiden?
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(3):528-9.
-
2006: Garufi Carlo; Vanni Barbara; Aschelter Anna Maria; Zappalà Albina Rita; Bria Emilio; Nisticò Cecila; Sperduti Isabella; Cognetti Francesco; Terzoli Edmondo
Randomised phase II study of standard versus chronomodulated CPT-11 plus chronomodulated 5-fluorouracil and folinic acid in advanced colorectal cancer patients.
European journal of cancer (Oxford, England : 1990) 2006;42(5):608-16.
-
2006: Rosell Rafael; Cecere Fabiana; Cognetti Francesco; Cuello Mauricio; Sanchez Jose Miguel; Taron Miquel; Reguart Noemi; Jablons David
Future directions in the second-line treatment of non-small cell lung cancer.
Seminars in oncology 2006;33(1 Suppl 1):S45-51.
-
2006: Ruggeri Enzo Maria; Giannarelli Diana; Bria Emilio; Carlini Paolo; Felici Alessandra; Nelli Fabrizio; Gallucci Michele; Cognetti Francesco; Pollera Camillo Francesco
Adjuvant chemotherapy in muscle-invasive bladder carcinoma: a pooled analysis from phase III studies.
Cancer 2006;106(4):783-8.
-
2006: Ferretti G; Carlini P; Bria E; Felici A; Giannarelli D; Ciccarese M; Papaldo P; Fabi A; Cognetti F
Chemotherapy-induced amenorrhea in early breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(2):352.
-
2006: Di Costanzo F; Gasperoni S; Papaldo P; Bilancia D; Manzione L; Landucci E; Mazzoni F; Cognetti F;
Weekly paclitaxel plus capecitabine in advanced breast cancer patients: dose-finding trial of GOIRC and GOL.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(1):79-84.
-
2006: Felici Alessandra; Carlini Paolo; Ruggeri Enzo Maria; Gamucci Teresa; Pollera Camillo Franco; De Marco Salvatore; Fariello Anna Maria; Moscetti Luca; Gelibter Alain; Adami Ennio; Sperduti Isabella; Cognetti Francesco
Bi-weekly chemotherapy with cisplatin, epirubicin, folinic acid and 5-fluororacil continuous infusion plus g-csf in advanced gastric cancer: a multicentric phase II study.
Cancer chemotherapy and pharmacology 2006;57(1):59-64.
-
2006: Spugnini Enrico P; Bosari Silvano; Citro Gennaro; Lorenzon Italo; Cognetti Francesco; Baldi Alfonso
Human malignant mesothelioma: molecular mechanisms of pathogenesis and progression.
The international journal of biochemistry & cell biology 2006;38(12):2000-4.
-
2005: Alimonti Andrea; Ferretti Gianluigi; Cognetti Francesco
Can the reliance of hormone receptor assays of surgical specimens be explained by the fluctuation of estrogen receptor, progesterone receptor, and HER-2 protein expression in tumor samples of premenopausal breast cancer patients?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(34):8918; author reply 8918-9.
-
2005: Gelibter Alain; Ceribelli Anna; Pollera Camillo F; Milella Michele; Moscetti Luca; Sperduti Isabella; Cognetti Francesco
Impact of gefitinib ('Iressa') treatment on the quality of life of patients with advanced non-small-cell lung cancer.
Journal of cancer research and clinical oncology 2005;131(12):783-8.
-
2005: Fabi Alessandra; Salesi Nello; Vidiri Antonello; Mirri Alessandra; Ferraresi Virginia; Cognetti Francesco
Retroperitoneal liposarcoma with metastasis to both orbits: an unusual metastatic site.
Anticancer research 2005;25(6C):4769-71.
-
2005: Pino Maria S; Nawrocki Steffan T; Cognetti Francesco; Abruzzese James L; Xiong Henry Q; McConkey David J
Prostaglandin E2 drives cyclooxygenase-2 expression via cyclic AMP response element activation in human pancreatic cancer cells.
Cancer biology & therapy 2005;4(11):1263-9.
-
2005: Ferretti Gianluigi; Bria Emilio; Giannarelli Diana; Carlini Paolo; Felici Alessandra; Mandala Mario; Papaldo Paolo; Nistico Cecilia; Fabi Alessandra; Cuppone Federica; Gelibter Alain; Terzoli Edmondo; Cognetti Francesco
Low-molecular-weight heparin versus oral anticoagulant therapy for the long-term treatment of symptomatic venous thromboembolism: Is there any difference in cancer-related mortality?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(28):7248-50; author reply 7250.
-
2005: Ferraresi Virginia; Ciccarese Mariangela; Zeuli Massimo; Cognetti Francesco
Central nervous system as exclusive site of disease in patients with melanoma: treatment and clinical outcome of two cases.
Melanoma research 2005;15(5):467-9.
-
2005: Carlini Paolo; Bria Emilio; Giannarelli Diana; Ferretti Gianluigi; Felici Alessandra; Papaldo Paola; Fabi Alessandra; Nisticò Cecilia; Di Cosimo Serena; Ruggeri Enzo Maria; Milella Michele; Mottolese Marcella; Terzoli Edmondo; Cognetti Francesco
New aromatase inhibitors as second-line endocrine therapy in postmenopausal patients with metastatic breast carcinoma: a pooled analysis of the randomized trials.
Cancer 2005;104(7):1335-42.
-
2005: Fabi A; Salesi N; Di Cocco B; Vidiri A; Visca P; Pace A; Carapella C; De Paula U; Mirri A; Cognetti F
Choroid plexus carcinoma in the adult: is there a role for chemotherapy?
Journal of experimental & clinical cancer research : CR 2005;24(3):493-6.
-
2005: Alimonti Andrea; Nardoni Chiara; Papaldo Paola; Ferretti Gianluigi; Caleno Maria Pia; Carlini Paolo; Fabi Alessandra; Rasio Debora; Vecchione Aldo; Cognetti Francesco
Nail disorders in a woman treated with ixabepilone for metastatic breast cancer.
Anticancer research 2005;25(5):3531-2.
-
2005: Gelibter Alain; Malaguti Paola; Di Cosimo Serena; Bria Emilio; Ruggeri Enzo Maria; Carlini Paolo; Carboni Fabio; Ettorre Giuseppe Maria; Pellicciotta Mario; Giannarelli Diana; Terzoli Edmondo; Cognetti Francesco; Milella Michele
Fixed dose-rate gemcitabine infusion as first-line treatment for advanced-stage carcinoma of the pancreas and biliary tree.
Cancer 2005;104(6):1237-45.
-
2005: Marty Michel; Cognetti Francesco; Maraninchi Dominique; Snyder Ray; Mauriac Louis; Tubiana-Hulin Michèle; Chan Stephen; Grimes David; Antón Antonio; Lluch Ana; Kennedy John; O'Byrne Kenneth; Conte PierFranco; Green Michael; Ward Carol; Mayne Karen; Extra Jean-Marc
Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(19):4265-74.
-
2005: Di Cosimo S; Ferretti G; Papaldo P; Carlini P; Fabi A; Ruggeri E M; Alimonti A; Nardoni C; Cognetti F
Does the concurrent use of anthracycline and granulocyte colony-stimulating factor influence the risk of secondary leukaemia in breast cancer women?
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(7):1209-10.
-
2005: Salesi N; Carlini P; Ruggeri E M; Ferretti G; Bria E; Cognetti F
Prostate cancer: the role of hormonal therapy.
Journal of experimental & clinical cancer research : CR 2005;24(2):175-80.
-
2005: Ruggeri Enzo Maria; Carlini Paolo; Pollera Camillo Francesco; De Marco Salvatore; Ruscito Paolo; Pinnarò Paola; Nardi Mario; Giannarelli Diana; Cognetti Francesco
Long-term survival in locally advanced oral cavity cancer: an analysis of patients treated with neoadjuvant cisplatin-based chemotherapy followed by surgery.
Head & neck 2005;27(6):452-8.
-
2005: Ferretti Gianluigi; Mandalà Mario; Bria Emilio; Carlini Paolo; Papaldo Paola; Fabi Alessandra; Felici Alessandra; Cognetti Francesco
Lumpectomy and tamoxifen alone without additional radiotherapy for women 70 years of age or older with estrogen receptor-positive breast cancer.
Breast cancer research and treatment 2005;90(3):319.
-
2005: Fabi A; Ferretti G; Salesi N; Papaldo P; Carlini P; Ciccarese M; Di Cocco B; Cecere F; Nardoni C; Felici A; Cognetti F
Can HER2 overexpression predict response to pegylated liposomal doxorubicin in metastatic breast cancer patients?
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(3):516-7.
-
2005: Bria Emilio; Giannarelli Diana; Felici Alessandra; Peters William P; Nisticò Cecilia; Vanni Barbara; Cuppone Federica; Cognetti Francesco; Terzoli Edmondo
Taxanes with anthracyclines as first-line chemotherapy for metastatic breast carcinoma.
Cancer 2005;103(4):672-9.
-
2005: Ferretti Gianluigi; Fabi Alessandra; Carlini Paolo; Papaldo Paola; Cordiali Fei Paola; Di Cosimo Serena; Salesi Nello; Giannarelli Diana; Alimonti Andrea; Di Cocco Barbara; D'Agosto Giovanna; Bordignon Valentina; Trento Elisabetta; Cognetti Francesco
Zoledronic-acid-induced circulating level modifications of angiogenic factors, metalloproteinases and proinflammatory cytokines in metastatic breast cancer patients.
Oncology 2005;69(1):35-43.
-
2005: Nisticò Cecilia; Cognetti Francesco; Frontini Luciano; Barni Sandro; Ferretti Gianluigi; Bria Emilio; Milella Michele; Garufi Carlo; Cuppone Federica; Vanni Barbara; Carlini Paolo; Terzoli Edmondo
Weekly docetaxel in pretreated metastatic breast cancer patients: a phase I-II study.
Oncology 2005;68(4-6):356-63.
-
2004: Ferretti G; Petti M C; Carlini P; Zeuli M; Picardi A; Meloni G; Bria E; Papaldo P; Fabi A; Cognetti F
Zoledronic acid-associated thrombotic thrombocytopenic purpura.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(12):1847-8.
-
2004: Milella Michele; Trisciuoglio Daniela; Bruno Tiziana; Ciuffreda Ludovica; Mottolese Marcella; Cianciulli Anna; Cognetti Francesco; Zangemeister-Wittke Uwe; Del Bufalo Donatella; Zupi Gabriella
Trastuzumab down-regulates Bcl-2 expression and potentiates apoptosis induction by Bcl-2/Bcl-XL bispecific antisense oligonucleotides in HER-2 gene--amplified breast cancer cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(22):7747-56.
-
2004: Alimonti Andrea; Gelibter Alain; Pavese Ida; Satta Francesco; Cognetti Francesco; Ferretti Gianluigi; Rasio Debora; Vecchione Aldo; Di Palma Mario
New approaches to prevent intestinal toxicity of irinotecan-based regimens.
Cancer treatment reviews 2004;30(6):555-62.
-
2004: Gelibter Alain; Milella Michele; Ceribelli Anna; Zeuli Massimo; Ferraresi Virginia; Vecchione Aldo; Cognetti Francesco
PET scanning evaluation of response to imatinib mesylate therapy in gastrointestinal stromal tumor (GIST) patients.
Anticancer research 2004;24(5B):3147-51.
-
2004: Fabi Alessandra; Vidiri Antonello; Carapella Carmine; Pace Andrea; Occhipinti Emanuele; Caroli Fabrizio; Mirri Alessandra; Carlini Paolo; Cognetti Francesco
Bone metastasis from glioblastoma multiforme without central nervous system relapse: a case report.
Anticancer research 2004;24(4):2563-5.
-
2004: Milella Michele; Gelibter Alain; Di Cosimo Serena; Bria Emilio; Ruggeri Enzo Maria; Carlini Paolo; Malaguti Paola; Pellicciotta Mario; Terzoli Edmondo; Cognetti Francesco
Pilot study of celecoxib and infusional 5-fluorouracil as second-line treatment for advanced pancreatic carcinoma.
Cancer 2004;101(1):133-8.
-
2004: Di Cosimo S; Alimonti A; Ferretti G; Sperduti I; Carlini P; Papaldo P; Fabi A; Gelibter A; Ciccarese M; Giannarelli D; Mandalà M; Milella M; Ruggeri E M; Cognetti F
Incidence of chemotherapy-induced amenorrhea depending on the timing of treatment by menstrual cycle phase in women with early breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(7):1065-71.
-
2004: Terzoli E; Nisticò C; Fabi A; Milella M; Bria E; D'Ottavio A M; Vaccaro A; Vanni B; Garufi C; Ferraresi V; Giannarelli D; Papaldo P; Carlini P; Izzo F; Cognetti F
Single-agent vinorelbine in pretreated breast cancer patients: comparison of two different schedules.
Journal of experimental & clinical cancer research : CR 2004;23(2):207-13.
-
2004: Fabi Alessandra; Papaldo Paola; Pino Maria Simona; Ferretti Gianluigi; Carlini Paolo; Pacetti Umberto; Di Cosimo Serena; Nardoni Chiara; Giannarelli Diana; Sacchi Italo; Cognetti Francesco
Epirubicin plus docetaxel in metastatic breast cancer: escalating dose does not improve efficacy. A phase II study.
Anticancer research 2004;24(3b):1963-7.
-
2004: Bernier Jacques; Domenge Christian; Ozsahin Mahmut; Matuszewska Katarzyna; Lefèbvre Jean-Louis; Greiner Richard H; Giralt Jordi; Maingon Philippe; Rolland Frédéric; Bolla Michel; Cognetti Francesco; Bourhis Jean; Kirkpatrick Anne; van Glabbeke Martine;
Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer.
The New England journal of medicine 2004;350(19):1945-52.
-
2004: Di Cocco Barbara; Salesi Nello; Fabi Alessandra; Nardoni Chiara; Ferretti Gianluigi; Bossone Giandominik; Ciccarese Mariangela; Savarese Antonella; Vecchione Aldo; Cognetti Francesco
Alfa-epoietin and anaemia in gynaecological cancer.
Anticancer research 2004;24(2C):1287-92.
-
2004: Salesi Nello; Fabi Alessandra; Di Cocco Barbara; Marandino Ferdinando; Pizzi Giuseppe; Vecchione Aldo; Cognetti Francesco
Testis metastasis as an initial manifestation of an occult gastrointestinal cancer.
Anticancer research 2004;24(2C):1093-6.
-
2004: Fabi A; Barduagni M; Ferraresi V; Cortesi E; Gamucci T; De Marinis F; Saltarelli R; Gabriele A; Pellicciotta M; Ceribelli A; De Marco S; Facciolo F; Cognetti F
The combination of carboplatin and weekly paclitaxel: a safe and active regimen in advanced non small-cell lung cancer patients. A phase I-II study.
Journal of experimental & clinical cancer research : CR 2004;23(1):25-32.
-
2004: Botti Claudio; Buglioni Simonetta; Benevolo Maria; Giannarelli Diana; Papaldo Paola; Cognetti Francesco; Vici Patrizia; Di Filippo Franco; Del Nonno Franca; Venanzi Franco Maria; Natali Pier Giorgio; Mottolese Marcella
Altered expression of FAS system is related to adverse clinical outcome in stage I-II breast cancer patients treated with adjuvant anthracycline-based chemotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(4):1360-5.
-
2004: Ferretti Gianluigi; Di Cosimo Serena; Giannarelli Diana; Carlini Paolo; Papaldo Paola; Alimonti Andrea; Fabi Alessandra; Mandalà Mario; Milella Michele; Ruggeri Enzo Maria; Cognetti Francesco
HER2/neu expression and hormonal therapy in early breast cancer: can muddy waters become clear?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(3):568-9.
-
2004: Papaldo Paola; Di Cosimo Serena; Ferretti Gianluigi; Vici Patrizia; Marolla Paolo; Carlini Paolo; Fabi Alessandra; Cognetti Francesco
Effect of filgrastim on serum lactate dehydrogenase and alkaline phosphatase values in early breast cancer patients.
Cancer investigation 2004;22(4):650-3.
-
2003: Savarese Antonella; Cognetti Francesco
New drugs in the treatment of recurrent or metastatic cervical cancer.
Critical reviews in oncology/hematology 2003;48(3):323-7.
-
2003: Scagliotti Giorgio V; Fossati Roldano; Torri Valter; Crinò Lucio; Giaccone Giuseppe; Silvano Giovanni; Martelli Massimo; Clerici Maurizia; Cognetti Francesco; Tonato Maurizio;
Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell Lung cancer.
Journal of the National Cancer Institute 2003;95(19):1453-61.
-
2003: Gelibter A; Ceribelli A; Milella M; Mottolese M; Vocaturo A; Cognetti F
Clinically meaningful response to the EGFR tyrosine kinase inhibitor gefitinib ('Iressa', ZD1839) in non small cell lung cancer.
Journal of experimental & clinical cancer research : CR 2003;22(3):481-5.
-
2003: Zeuli M; Nardoni C; Pino M S; Gamucci T; Gabriele A; Ferraresi V; Giannarelli D; Cognetti F
Phase II study of capecitabine and oxaliplatin as first-line treatment in advanced colorectal cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(9):1378-82.
-
2003: Cocconi G; Carlini P; Gamboni A; Gasperoni S; Rodinò C; Zironi S; Bisagni G; Porrozzi S; Cognetti F; Di Costanzo F; Canaletti R; Ruggeri E M; Camisa R; Pucci F;
Cisplatin, epirubicin, leucovorin and 5-fluorouracil (PELF) is more active than 5-fluorouracil, doxorubicin and methotrexate (FAMTX) in advanced gastric carcinoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(8):1258-63.
-
2003: Carlini Paolo; Ferretti Gianluigi; Di Cosimo Serena; Colella Elvira; Tonachella Riccardo; Romiti Adriana; Tomao Silverio; Frassoldati Antonio; Papaldo Paola; Fabi Alessandra; Ruggeri Enzo Maria; Cognetti Francesco
Is there a benefit by the sequence anastrozole-formestane for postmenopausal metastatic breast cancer women?
The Journal of steroid biochemistry and molecular biology 2003;86(1):107-9.
-
2003: Ceribelli Anna; Gridelli Cesare; De Marinis Filippo; Fabi Alessandra; Gamucci Teresa; Cortesi Enrico; Barduagni Maria; Antimi Mauro; Maione Paolo; Migliorino Maria R; Giannarelli Diana; Cognetti Francesco
Prolonged gemcitabine infusion in advanced non-small cell lung carcinoma: a randomized phase II study of two different schedules in combination with cisplatin.
Cancer 2003;98(2):337-43.
-
2003: Di Cosimo Serena; Ferretti Gianluigi; Papaldo Paola; Carlini Paolo; Fabi Alessandra; Cognetti Francesco
Lonidamine: efficacy and safety in clinical trials for the treatment of solid tumors.
Drugs of today (Barcelona, Spain : 1998) 2003;39(3):157-74.
-
2003: Fabi Alessandra; Barduagni Mario; Lauro Salvatore; Portalone Luigi; Mauri Mariella; Marinis Filippo; Narduzzi Carla; Tonini Giuseppe; Giampaolo Marianna; Pacetti Umberto; Paoloni Francesca; Cognetti Francesco
Is delayed chemotherapy-induced emesis well managed in oncological clinical practice? An observational study.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2003;11(3):156-61.
-
2003: Pace Andrea; Savarese Antonella; Picardo Mauro; Maresca Vittoria; Pacetti Umberto; Del Monte Girolamo; Biroccio Annamaria; Leonetti Carlo; Jandolo Bruno; Cognetti Francesco; Bove Loredana
Neuroprotective effect of vitamin E supplementation in patients treated with cisplatin chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(5):927-31.
-
2003: Leonetti Carlo; Biroccio Annamaria; Gabellini Chiara; Scarsella Marco; Maresca Vittoria; Flori Enrica; Bove Loredana; Pace Andrea; Stoppacciaro Antonella; Zupi Gabriella; Cognetti Francesco; Picardo Mauro
Alpha-tocopherol protects against cisplatin-induced toxicity without interfering with antitumor efficacy.
International journal of cancer. Journal international du cancer 2003;104(2):243-50.
-
2003: Di Cosimo Serena; Ferretti Gianluigi; Fazio Nicola; Silvestris Nicola; Carlini Paolo; Alimonti Andrea; Gelibter Alain; Felici Alessandra; Papaldo Paola; Cognetti Francesco
Docetaxel in advanced gastric cancer--review of the main clinical trials.
Acta oncologica (Stockholm, Sweden) 2003;42(7):693-700.
-
2002: Ferretti Gianluigi; Di Cosimo Serena; Carlini Paolo; Papaldo Paola; Fabi Alessandra; Cognetti Francesco
Re: Mastectomy and oophorectomy by menstrual cycle phase in women with operable breast cancer.
Journal of the National Cancer Institute 2002;94(22):1720; author reply 1721-2.
-
2002: Arcangeli Giorgio; Saracino Biancamaria; Danesi Donatella Tirindelli; De Campora Enrico; Giovinazzo Giuseppe; Cognetti Francesco; Carlini Paolo; Arcangeli Stefano; Mecozzi Antonella
Accelerated hyperfractionated radiotherapy and concurrent protracted venous infusion chemotherapy in locally advanced head and neck cancer.
American journal of clinical oncology 2002;25(5):431-7.
-
2002: Savarese A; Cognetti F
Perspectives in the clinical management of BRCA mutations carriers.
Journal of experimental & clinical cancer research : CR 2002;21(3 Suppl):31-5.
-
2002: Serrone L; Nardoni C; Gelibter A; Felici A; Cognetti F
Salvage chemotherapy for advanced sarcoma patients: a single-institution experience survey.
Journal of experimental & clinical cancer research : CR 2002;21(2):181-4.
-
2001: Zeuli M; Costanzo E D; Sdrobolini A; Gasperoni S; Paoloni F P; Carpi A; Moscetti L; Cherubini R; Cognetti F;
Capecitabine and oxaliplatin in advanced colorectal cancer: a dose-finding study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(12):1737-41.
-
2001: Carlini P; Frassoldati A; De Marco S; Casali A; Ruggeri E M; Nardi M; Papaldo P; Fabi A; Paoloni F; Cognetti F
Formestane, a steroidal aromatase inhibitor after failure of non-steroidal aromatase inhibitors (anastrozole and letrozole): is a clinical benefit still achievable?
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(11):1539-43.
-
2001: Serrone L; Zeuli M; Papaldo P; Nardoni C; Pacetti U; Cognetti F
Ifosfamide and epirubicin combination in untreated sarcomas: two treatment schedules.
Onkologie 2001;24(5):465-8.
-
2001: Nardi M; De Marco S; Fabi A; Aloe A; Magnani E; Pacetti U; Carlini P; Ruggeri E M; Cognetti F
Cisplatin and escalating doses of paclitaxel and epirubicin in advanced ovarian cancer. A phase I study.
Cancer chemotherapy and pharmacology 2001;48(3):255-8.
-
2001: Venturini M; Michelotti A; Papaldo P; Del Mastro L; Bergaglio M; Lionetto R; Lunardi G; Sguotti C; Frevola L; Donati S; Rosso R; Cognetti F
Identification of the highest dose of docetaxel associable with active doses of epirubicin. Results from a dose-finding study in advanced breast cancer patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(8):1097-106.
-
2001: Guadagni F; Ferroni P; Carlini S; Mariotti S; Spila A; Aloe S; D'Alessandro R; Carone M D; Cicchetti A; Ricciotti A; Venturo I; Perri P; Di Filippo F; Cognetti F; Botti C; Roselli M
A re-evaluation of carcinoembryonic antigen (CEA) as a serum marker for breast cancer: a prospective longitudinal study.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(8):2357-62.
-
2001: D'Alessandro R; Roselli M; Ferroni P; Mariotti S; Spila A; Aloe S; Carone M D; Abbolito M R; Carlini S; Perri P; Ricciotti A; Botti C; Conti F; Vici P; Chiappetta N R; Cognetti F; Buonomo O; Guadagni F
Serum tissue polypeptide specific antigen (TPS): a complementary tumor marker to CA 15-3 in the management of breast cancer.
Breast cancer research and treatment 2001;68(1):9-19.
-
2001: Serrone L; Zeuli M; Gamucci T; Nardi M; Cognetti F
A phase II study of dose-intense ifosfamide plus epirubicin with hematopoietic growth factors for the treatment of patients with advanced soft tissue sarcomas; a novel sequential schedule.
Cancer chemotherapy and pharmacology 2001;47(3):206-10.
-
2001: Zeuli M; Pino M S; Cognetti F
[Capecitabine in the treatment of colorectal cancer]
Tumori 2001;87(1 Suppl 1):S55-6.
-
2000: Ferraresi V; Milella M; Vaccaro A; D'Ottavio A M; Papaldo P; Nisticò C; Thorel M F; Marsella A; Carpino A; Giannarelli D; Terzoli E; Cognetti F
Toxicity and activity of docetaxel in anthracycline-pretreated breast cancer patients: a phase II study.
American journal of clinical oncology 2000;23(2):132-9.
-
2000: Serrone L; Zeuli M; Sega F M; Cognetti F
Dacarbazine-based chemotherapy for metastatic melanoma: thirty-year experience overview.
Journal of experimental & clinical cancer research : CR 2000;19(1):21-34.
-
2000: De Santis S; Pace A; Bove L; Cognetti F; Properzi F; Fiore M; Triaca V; Savarese A; Simone M D; Jandolo B; Manzione L; Aloe L
Patients treated with antitumor drugs displaying neurological deficits are characterized by a low circulating level of nerve growth factor.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(1):90-5.
-
2000: Nardi M; De Marco S; Fabi A; Aloe A; Magnani E; Grandinetti P; Cognetti F
Ifosfamide and vinorelbine in advanced pretreated ovarian cancer: a phase II study.
Cancer chemotherapy and pharmacology 2000;45(6):513-5.
-
1999: Scinto A F; Ferraresi V; Milella M; Tucci E; Santomaggio C; Pasquali-Lasagni R; Del Vecchio M R; Campioni N; Nardi M; Cognetti F
Ifosfamide, cisplatin and etoposide combination in locally advanced inoperable non-small-cell lung cancer: a phase II study.
British journal of cancer 1999;81(6):1031-6.
-
1999: De Marco S; Pollera C F; Cognetti F
Nephroblastoma in the adult.
Medical and pediatric oncology 1999;33(5):497-9.
-
1999: De Marco S; Fabi A; Ceribelli A; Carlini P; Pollera C F; Cognetti F
Does pain at tumor site during vinorelbine infusion affect treatment of recurrent head and neck cancer patients?
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(7):865-6.
-
1999: Milella M; Nisticò C; Ferraresi V; Vaccaro A; Fabi A; D'Ottavio A M; Botti C; Giannarelli D; Lopez M; Cortesi E; Foggi C M; Antimi M; Terzoli E; Cognetti F; Papaldo P
Breast cancer and timing of surgery during menstrual cycle: a 5-year analysis of 248 premenopausal women.
Breast cancer research and treatment 1999;55(3):259-66.
-
1997: Nardi M; Aloe A; De Marco S; Cognetti F; Iacovelli A; Atlante G; Calabresi F
Paclitaxel as salvage therapy in advanced pretreated ovarian cancer: a phase II study.
American journal of clinical oncology 1997;20(3):230-2.
-
1996: Gridelli C; Perrone F; Palmeri S; D'Aprile M; Cognetti F; Rossi A; Gebbia V; Pepe R; Veltri E; Airoma G; Russo A; Incoronato P; Scinto A F; Palazzolo G; Natali M; Leonardi V; Gallo C; De Placido S; Bianco A R
Mitomycin C plus vindesine plus etoposide (MEV) versus mitomycin C plus vindesine plus cisplatin (MVP) in stage IV non-small-cell lung cancer: A phase III multicentre randomised trial. The "Gruppo Oncologico Centro-Sud-Isole' (G.O.C.S.I.).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(8):821-6.
-
1995: Scinto A F; Ferraresi V; Campioni N; Tonachella R; Piarulli L; Sacchi I; Giannarelli D; Cognetti F
Accelerated chemotherapy with high-dose epirubicin and cyclophosphamide plus r-met-HUG-CSF in locally advanced and metastatic breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1995;6(7):665-71.
-
1995: Botti C; Vici P; Lopez M; Scinto A F; Cognetti F; Cavaliere R
Prognostic value of lymph node metastases after neoadjuvant chemotherapy for large-sized operable carcinoma of the breast.
Journal of the American College of Surgeons 1995;181(3):202-8.
-
1995: Fabi A; Tonachella R; Savarese A; Cirulli S; Tomao S; Conte E; Cognetti F
A phase II trial of vinorelbine and thiotepa in metastatic breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1995;6(2):187-9.
-
1994: Pinnarò P; Cercato M C; Giannarelli D; Carlini P; Del Vecchio M R; Impiombato F A; Marzetti F; Milella M; Cognetti F
A randomized phase II study comparing sequential versus simultaneous chemo-radiotherapy in patients with unresectable locally advanced squamous cell cancer of the head and neck.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(6):513-9.
-
1994: Scinto A F; Cercato M C; Botti C; Tonachella R; Ferraresi V; Del Bianco S; Sacchi I; Cognetti F
Phase II trial of high-dose epirubicin and cyclophosphamide in advanced breast cancer.
European journal of cancer (Oxford, England : 1990) 1994;30A(9):1285-8.
-
1994: Colella E; Merlano M; Blengio F; Angelini F; Ausili Cefaro G P; Scasso F; Lo Russo V; Cirulli S; Giannarelli D; Cognetti F
Randomised phase II study of methotrexate (MTX) versus methotrexate plus lonidamine (MTX + LND) in recurrent and/or metastatic carcinoma of the head and neck.
European journal of cancer (Oxford, England : 1990) 1994;30A(7):928-30.
-
1991: Roila F; Tonato M; Cognetti F; Cortesi E; Favalli G; Marangolo M; Amadori D; Bella M A; Gramazio V; Donati D
Prevention of cisplatin-induced emesis: a double-blind multicenter randomized crossover study comparing ondansetron and ondansetron plus dexamethasone.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(4):675-8.
-
1991: Cercato M C; La Ferla G; Pericoli N; Fedele Scinto A; Sacchi I; Cognetti F
Cardiac tamponade as the initial manifestation of extracardiac malignancy.
European journal of cancer (Oxford, England : 1990) 1991;27(5):670-1.
-
1990: Nardi M; Cognetti F; Pollera C F; Giulia M D; Lombardi A; Atlante G; Calabresi F
Intraperitoneal recombinant alpha-2-interferon alternating with cisplatin as salvage therapy for minimal residual-disease ovarian cancer: a phase II study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(6):1036-41.
-
1989: Cognetti F; Pinnarö P; Ruggeri E M; Carlini P; Perrino A; Impiombato F A; Calabresi F; Chilelli M G; Giannarelli D
Prognostic factors for chemotherapy response and survival using combination chemotherapy as initial treatment of advanced head and neck squamous cell cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(7):829-37.
-
1988: Cognetti F; Pinnarò P; Carlini P; Ruggeri E M; Ambesi Impiombato F; Del Vecchio M R; Giannarelli D; Perrino A
Neoadjuvant chemotherapy in previously untreated patients with advanced head and neck squamous cell cancer.
Cancer 1988;62(2):251-61.
-
1987: Cognetti F; Molinari A; Carlini P; Frassineti G L; Pinnarò P; Marangolo M
Alternating regimens in recurrent and metastatic squamous cell carcinoma of the head and neck.
Oncology 1987;44(5):270-2.
-
1986: Pinnarò P; Ruggeri E M; Carlini P; Giovannelli M; Cognetti F
Cumulative or delayed nephrotoxicity after cisplatin (DDP) treatment.
Tumori 1986;72(2):197-200.
-
1986: Cognetti F; Carlini P; Pinnarò P; Ruggeri E M; Caporali C
Maintenance of antiemetic effect of a metoclopramide-dexamethasone combination during subsequent cisplatin courses.
Oncology 1986;43(5):292-4.
-
1984: Cognetti F; Pinnarò P; Carlini P; Conti E M; Cortese M; Pollera C F
Randomized open cross-over trial between metoclopramide (MCP) and dexamethazone (DXM) for the prevention of cisplatin-induced nausea and vomiting.
European journal of cancer & clinical oncology 1984;20(2):183-7.
-
1984: Cognetti F; Pinnaro P; Carlini P; Caporali C; Ruggeri E M; Pollera C F
Improved control of cisplatin-induced emesis with a metoclopramide-dexamethasone combination.
Cancer chemotherapy and pharmacology 1984;13(3):235-7.
Sign-in to see more
